In a pool of two ZEPBOUND clinical studies for weight reduction (Studies 1 and 2), 0.1% of ZEPBOUND-treated patients had severe hypersensitivity reactions compared to no placebo-treated patients
We brought together a peptide studied in preclinical models for its role in gut barrier comfort, clinically researched pre- and probiotics to nourish the microbiome, and targeted tributyrin to deliver butyrate where its needed most
This dual mechanism produces greater weight loss than GLP-1 monotherapy aloneclinical trials show average reductions of 22% body weight over 68 weekswhile simultaneously improving fasting glucose, HbA1c, and insulin levels
Key differences of B12 shots vs oral B12 Who benefits most from Vitamin B12 injections
At a glance Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes
Semaglutide specifically showed an average weight loss of 9.2 percent in patients with overweight and obesity over 68 weeks in SUSTAIN 12